Generate a tailored SOP for Dr. Giorgio Inghirami. Improve your application with a focused, well-structured draft.
Giorgio Inghirami is a practicing hematopathologist and Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College since September 2013. He has over 20 years of experience in molecular biology, focusing on the pathogenetic defects in lymphoproliferative disorders. His research emphasizes the detection of abnormalities that improve diagnostic accuracy and provide clinically-proven stratification in patient-specific genomic fingerprints. This approach aims to better predict clinical outcomes and tailor therapies. Dr. Inghirami has significantly advanced the understanding of Minimal Residual Disease (MRD) in individual leukemia and lymphoma patients, optimizing therapeutic programs accordingly. He has contributed to more than 160 peer-reviewed publications, primarily in lymphoma research, and has been involved in international patents as a Principal Investigator on NIH-NCI and European Union Italian grants. Furthermore, he co-founded the European T-Cell Lymphoma Study Group and has extensive laboratory experience employing advanced techniques such as deep sequencing and high-density microarrays to study T-cell lymphoma and Non-Small Cell Lung Cancers (NSCLC). Dr. Inghirami has held prominent roles as Director of Molecular Pathology and Hematopathology at New York University and Director of Anatomic Pathology at the University of Torino, Italy, contributing to significant educational and research advancements in the field.
Weill Cornell Medical College • New York, NY
Professor of Pathology and Laboratory Medicine with a focus on hematopathology.
NewYork-Presbyterian Hospital • New York, NY
Clinical responsibilities in pathology.
Department of Architecture